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ABSTRACT  
In diabetic patients, hyperglycemia is developed due to increased hepatic glucose production and impaired utilization of glucose in cells, which 
leads to oxidative stress in cells. Ipomoea pes-caprae has been widely used as an oral treatment for many diseases. The aim of the present study 
is to assess the effect of Ipomoea pes-caprae ethanolic leaf extract on carbohydrate metabolizing enzymes and oxidative status in Streptozotocin 
(STZ) induced experimental diabetic rats. Experimental diabetic rats were induced by intraperitoneal administration of 55 mg/ kg b.w of STZ. 
Diabetic rats were treated with I. pes-caprae ethanolic leaf extract at a concentration of 300 mg/kg b.w and glibenclamide (6 mg/kg b.w) for 45 
days. Diabetic rats exhibited significant (P < 0.05) decline in the activity of glucokinase and glucose-6-phosphate dehydrogenase, enzymatic 
antioxidants (SOD, CAT and GPx) and non-enzymatic antioxidants (GSH, vitamin E and vitamin C), while lipid peroxidation markers (LOOH and 
TBARS) and glucose-6-phosphatase and fructose-1, 6-bisphosphatase were found to be significantly increased. Further in diabetic rats, the 
histopathology of pancreas, liver and kidney showed abnormal histo-architecture. The treatment with Ipomoea pes-caprae ethanolic leaf extract 
notably reversed the abnormal levels in carbohydrate metabolizing enzymes, restored the oxidative status and abnormal structures in 
pancreas, liver and kidney to near normal levels.  
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1. INTRODUCTION 
Diabetes mellitus (DM), a metabolic disorder, is 
characterized by disruption in the endocrine system due to 
multiple etiological factors, including chronic hyperglycemia 
and altered carbohydrate, fats, and proteins metabolism, 
which is caused by the defects in insulin secretion and/or 
action [1]. The prevalence of DM is expected to further 
increase to 9.9% (95% CI 7.5-12.7%) by the year 2045. In 
total, this reflects a population of 424.9 million people with 
diabetes worldwide in 2017 with an estimate of a 48% 
increase to 628.6 million people (95% CI 477.0-808.7 
million) for the year 2045 [2].   
The chronic hyperglycemia may lead to long-term oxidative 
cellular injury and dysfunction of various organs, 
particularly the kidneys, eyes, nerves, liver, heart, and blood 
vessels. The provoked oxidative stress and lipid 
peroxidation act as a potential pathophysiological 
mechanism underlying diabetic complications through the 
overproduction of reactive oxygen species and by triggering 
the production of proinflammatory cytokines, which 
together with reactive oxygen species are deemed to play 
vital roles in the pathogenesis of DM [3]. 
Nowadays, the utilization of herbal derived drugs has 
increased because of their superior activity, lesser side 
effects, as well as relatively low production cost. Thus, 
screening of novel antidiabetic alternative drugs from 
natural plant sources is of profound importance for the 
world [4].  
I. pes-caprae is a common pan-tropical creeping vine 
belonging to the family Convolvulaceae. This plant is used as 
a medicinal plant in many countries for the treatment of 
several ailments, including anti-inflammatory and analgesic 
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treatments [5]. All parts of I. pes-caprae are medicinally 
useful and are used in folk and traditional medicines for 
treating different diseases like stomach pain, fever and 
rheumatoid arthritis, etc., [6]. Earlier, some researchers 
reported that I. pes-caprae shows many biological activities 
such as anti-inflammatory activity Venkataraman et al. [7], 
anticancer activity Robert and Retna [8], antibacterial and 
antifungal activities (Bragadeeswaranet et al. [9] etc. Earlier, 
we reported that ethanolic leaf extract of I. pes-caprae 
regulated the abnormal blood glucose level and hepatic 
markers in STZ induced diabetic rats (Suhasini et al. [10]. 
The objective of this present study is to observe the effect of 
ethanolic leaf extract of I. pes-capraeon on carbohydrate 
metabolizing enzymes, oxidative status and major organs 
(pancreas, liver and kidney) in STZ induced diabetic rats.  
2. MATERIALS AND METHODS 
2.1. Experimental animals  
Male Wistar rats weighing 150-200 gms were used for the 
present study. The animals were obtained from the central 
animal house, Rajah Muthiah Institute of Health Sciences, 
Annamalai University, India and were maintained at 12h 
light: dark cycles. All the animals were randomly divided 
into experimental and control groups. Animals were housed 
as 5 or 6 in each polypropylene cage. Standard pellets were 
obtained from Mysore snack feed Ltd., Mysore, was used as a 
basal diet during the entire experimental period. The control 
and the experimental animals were provided with food and 
drinking water ad libitum.  
2.2. Chemicals 
STZ was purchased from Sigma- Aldrich Pvt. Ltd., Bangalore, 
India. All the other chemicals as well as reagents used in this 
experiment were of analytical grade. 
2.3. Preparation of ethanolic leaf extract of Ipomoea pes-
caprae 
I. pes-caprae was collected from Parangipettai, Tamil Nadu, 
India, and was identified by the Department of Botany, 
Annamalai University. The  Ipomoea  pes-caprae 
(Convolvulaceae) leaves were then separated and dried at 
room temperature, under the shade, and  was powdered  
using a dry grinder and then passed through a sieve. Dried 
leaf powder (100 grams) of I. pes-caprae was packed in a 
soxhlet apparatus and was extracted with ethanol. The 
ethanol extract obtained was concentrated using a rotary 
evaporator. 
2.4. Induction of diabetes  
Diabetes was induced in male albino Wistar rats by a single 
intraperitoneal (I.P.) injection of streptozotocin (STZ) at a 
dose of (55 mg/kg b.w) dissolved in 0.1 M cold citrate buffer 
(pH = 4.5). The rats were then allowed to drink 5% glucose 
solution overnight to overcome the drug-induced 
hypoglycemia. When the fasting blood glucose values 
reached above 250 mg/dl, on the third day after STZ 
injection, then the rats were considered as diabetic.  
2.5. Experimental design 
The animals were maintained in accordance with the 
“CPCSEA guidelines for laboratory animal facility” (CPCSEA: 
Committee for the purpose of control and supervision of 
experiments on animals) and the approval number is 
(Pro.No.1030; Reg No.160/1999/CPCSE). The treatment of 
ethanolic leaf extract of I. pes-caprae at concentration of 300 
mg/kg b.w (dissolved in 0.05% dimethxyl sulfoxide (DMSO)) 
and glibenclamide (reference drug) at concentration of 6 
mg/kg b.w was started on the fifth day after STZ injection 
and it was considered as the first day of treatment. 
Treatment was given for 45 days orally whereas control rats 
were administered with drug vehicle, i.e., 0.05% DMSO, and 
diabetic rats were fed with water alone. 
A total number of 24 rats were used and the rats were 
divided into 4 groups of 6 animals in each group. 
Group 1     :    Control rats (drug vehicle: 0.05% DMSO)  
Group 2     :    Diabetic control rats administered 
intraperitoneally with streptozotocin (as single dose: 55 
mg/kg b.w).  
Group 3     :   Diabetic rats administered with ethanolic 
extract of Ipomoea pes-caprae leaf (300 mg/kg of body 
weight) for a period of 45days. 
Group 4     :   Diabetic rats administered with reference drug 
glibenclamide (6 mg/kg of body weight) for a period of 45 
days. 
On the 45th day, all the animals were sacrificed by cervical 
dislocation, and the blood samples were collected for 
analysis of biochemical parameters. The pancreas, liver and 
kidney were excised and washed with ice-cold saline to 
observe levels of carbohydrate metabolizing enzymes, 
antioxidant status and histopathological analysis. 
2.6. Determination of carbohydrate metabolizing 
enzymes 
Liver glycogen was evaluated by the method of Shirwaikar et 
al. [11]. The activity of hepatic glucokinase by the method of 
Brandstrup et al. [12], glucose-6-phosphate dehydrogenase 
by the method of Ellis and Kirkman [13], glucose-6-
phosphatase by the method of Koide and Oda [14] and 
fructose-1, 6-bisphosphatase activity were estimated by the 
method of Gancedo and Gancedo [15].  
2.7. Estimation of lipid peroxidation and antioxidants  
The activity of the thiobarbituric acid reactive substance 
(TBARS) and lipid peroxide (LOOH) in the liver was 
measured by the method of Ohkawa [16]. The activity of 
superoxide dismutase (SOD) was evaluated by the method of 
Kakkar [17]. The activity of catalase (CAT) enzyme was 
measured by the method given by Sinha, [18]. Glutathione 
Peroxidase (GPx) was evaluated by the method of Rotruck 
[19]. The activity of reduced glutathione (GSH) was assessed 
by the method of Ellman, [20]. Vitamin C and E levels were 
evaluated by the method of Omaye et al. [21] and Baker and 
Frank [22], respectively. 
2.8. Histopathology 
The harvested organs (pancreas, liver and kidney) were 
fixed in 10 % formalin for 48hrs. It was then followed by 
dehydration by passing through a series of graded alcohol 
and were finally embedded in paraffin blocks. Sections of 
pancreas, liver and kidney (5-6 µm thick) were developed 
using semi-automated rotator microtome. Finally, the 
sections obtained were stained with Hematoxylin and Eosin 
(H & E) dye on a glass slide and observed microscopically.  
2.9. Statistical analysis  
All biochemical data were expressed as mean ± SEM.  All the 
statistical  analysis  was  performed  using  the One-way 
ANOVA  followed  by  Tukey’s  multiple  tests  using  SPSS 
(version 18) of computer software. In all the cases, a p value 
of less than 0.05 was considered to be statistically 
significant. 
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3. RESULTS  
3.1. Effect of Ipomoea pes-caprae on liver glycogen 
Figure 1 shows the level of liver glycogen in normal and 
experimental rats. The level of liver glycogen was 
significantly reduced in diabetic control rats when compared 
to control rats. Treatment with I.  pes-caprae leaf ethanolic 
extract and glibenclamide significantly improved the 
glycogen levels in the liver of diabetic rats when compared 
to diabetic control rats. 
 
 
3.2. Effect of Ipomoea pes-caprae on carbohydrate 
metabolizing enzymes 
Table 1 shows the level of carbohydrate metabolizing 
enzymes in experimental and control rats. The activity of 
hepatic glucokinase and glucose-6-phosphate 
dehydrogenase significantly declined, whereas glucose-6-
phosphatase and fructose-1, 6-bisphosphatase activity 
significantly elevated in the diabetic control rats. The 
abnormal levels of carbohydrate metabolizing enzymes were 
improved by I.  pes-caprae leaf ethanol extract and 
glibenclamide treatment. 
 
Table 1: The liver carbohydrate metabolizing enzyme levels in experimental and control rats 
Groups Hexokinase  
(U*/h/ mg protein) 
Glucose-6-phosphate 
dehydrogenase 
(U#/mg protein) 
Glucose-6 phosphatase 
(Unit@/min/ 
mg protein) 
Fructose 1,6-bis 
phosphatase (Unit$/h/ 
mg protein) 
Control 0.30 ± 0.03a 4.62 ± 0.36a 5.76 ± 0.41a 13.41 ± 0.99a 
Diabetic control 0.10 ± 0.01b 2.57 ± 0.19b 7.72 ± 0.61b 26.47 ± 2.05b 
D + I.p  (300 mg/kg bw) 0.25 ± 0.03c 3.79 ± 0.29c 6.15 ± 0.47c 16.44 ± 1.26c 
D + GC  (6 mg/kg bw) 0.28 ± 0.03ac 4.18 ± 0.42ac 5.47 ± 0.42ac 13.76 ± 1.01a 
All the data are expressed as the mean ± S.D. for 6 rats. The results with different superscripts (a,b,c..) in each experimental 
groups are significantly different at p < 0.05. 
(D: Diabetic; I.p: I. pes-caprae leaf ethanolic extract; GC: Glibenclamide)  
 
3.3. Effect of Ipomoea pes-caprae on lipid peroxidation 
TBARS and LOOH levels were significantly (p < 0.05) 
elevated in the organs (pancreas, liver and kidney) of 
diabetic control rats when compared to control rats, 
whereas diabetic rats treated with I. pes-caprae leaf ethanol 
extract and glibenclamide significantly inhibited the 
increased level of TBARS and LOOH as compared with 
diabetic control rats (Table 2). 
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Table 2: The levels of lipid peroxidation markers (TBARS and LOOH) in different tissues of experimental and control 
rats 
Groups Control Diabetic control 
D + I.p  
(300 mg) 
D + GC  
(6 mg) 
TBARS1 
Liver 0.79 ± 0.06a 3.09 ± 0.20b 1.77 ± 0.14c 1.47 ± 0.12c 
Kidney 1.32 ± 0.11a 3.32 ± 0.23b 2.19 ± 0.15c 1.63 ± 0.13a 
Pancreas 0.30 ± 0.03a 0.49 ± 0.03b 0.38 ± 0.03c 0.37 ± 0.03a 
LOOH2 
Liver 72.10  ± 5.54a 124.62  ± 9.66b 84.78  ± 6.61c 77.30  ± 5.72ac 
Kidney 66.77  ± 5.10a 153.17  ± 11.89b 78.68  ± 6.01c 75.18  ± 5.24ac 
Pancreas 16.54 ± 1.27a 29.38 ± 2.25b 18.63 ± 1.61c 17.27 ± 1.27ac 
1TBARS in tissues were expressed as µmoles/g tissue 
2LOOH in tissues were expressed as x10-5 mmoles/g tissue 
All the data are expressed as the mean ± S.D. for 6 rats. The results with different superscripts (a,b,c..) in each experimental group are 
significantly different at  p < 0.05. 
(D: Diabetic; I.p: I. pes-caprae leaf ethanolic extract; GC: Glibenclamide) 
 
3.4. Effect of Ipomoea pes-caprae on enzymatic 
antioxidant enzymes 
Table 3 depicts the enzymatic antioxidant activities in 
organs (pancreas, liver and kidney) of experimental and 
control rats. The activity of enzymatic antioxidant enzymes 
such as SOD, CAT and GPx were significantly declined in 
diabetes control rats when compared with control rats. I. 
pes-caprae leaf ethanol extract and glibenclamide treated 
diabetic rats showed significant improvement in the activity 
of SOD, CAT and GPx as compared to diabetic control rats.
 
Table 3: The levels of enzymatic antioxidants in different tissues of experimental and control rats 
Groups Control Diabetic control 
D + BC  
(50 mg) 
D + GC  
(6 mg) 
SOD1 
Liver 9.34 ± 0.71a 4.78 ± 0.34b 7.76 ± 0.62c 8.39 ± 0.67a 
Kidney 14.31 ± 1.10a 6.49 ± 0.52b 12.34 ± 0.93c 12.64 ± 1.01ac 
Pancreas 3.19 ± 0.24a 1.67 ± 0.12b 2.73 ± 0.20c 2.82 ± 0.21a 
CAT2 
Liver 80.06 ± 6.17a 51.67 ± 4.03b 67.78 ± 5.13c 70.35 ± 5.29ac 
Kidney 40.23 ± 3.07a 18.21 ± 1.38b 32.58 ± 2.51c 35.14 ± 2.71a 
Pancreas 0.74 ± 0.05a 0.39 ± 0.03b 0.64 ± 0.05c 0.72 ± 0.05a 
GPx3 
Liver 11.21 ± 0.87a 4.82 ± 0.37b 9.20 ± 0.71c 10.38 ± 0.79ac 
Kidney 8.38 ± 0.66a 4.26 ± 0.31b 6.59 ± 0.53c 7.64 ± 0.58a 
Pancreas 1.69 ± 0.12a 0.97 ± 0.08b 1.38 ± 0.11c 1.59 ± 0.12ac 
1SOD for tissues were expressed as 50% inhibition of nitroblue tetrazolium reduced in 1minute/mg protein 
2CAT for tissues were expressed as µmoles of H2O2 consumed/ minute/mg protein. 
3GPx for tissues were expressed as µg of GSH consumed /minute/mg protein 
All the data are expressed as the mean ± S.D. for 6 rats. The results with different superscripts (a, b, c..) in each experimental 
groups are significantly different at p < 0.05. 
(D: Diabetic; I.p: I. pes-caprae leaf ethanolic extract; GC: Glibenclamide) 
 
3.5. Effect of Ipomoea pes-caprae on non-enzymatic 
antioxidants 
Table 4 shows the level of non-enzymatic antioxidants in 
tissue (pancreas, liver and kidney) of control and 
experimental rats. The GSH, vitamin C and E levels were 
significantly declined in diabetic control rats when 
compared to control rats. These abnormal levels of non-
enzymatic antioxidants improved considerably to near 
normal levels in I. pes-caprae leaf ethanol extract and 
glibenclamide treated diabetic rats. 
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 Table 4: The levels of non-enzymatic antioxidants in different tissues of experimental and control rats 
Groups Control Diabetic control 
D + I. p  
(300 mg/kg bw) 
D + GC  
(6 mg/kg bw) 
GSH1 
Plasma 30.19 ± 2.39a 15.67 ± 1.17b 24.18 ± 1.79c 25.09 ± 1.89c 
Liver 13.36 ± 1.09a 8.07 ± 0.61b 11.79 ± 0.89c 12.88 ± 0.96ac 
Kidney 12.49 ± 0.96a 6.61 ± 0.50b 10.28 ± 0.80c 11.29 ± 0.86ac 
Heart 10.21 ± 0.78a 5.25 ± 0.41b 8.75 ± 0.68c 9.10 ±0.70ac 
Pancreas 1.78 ± 0.13a 0.90 ± 0.07b 1.39 ± 0.11c 1.55 ± 0.12a 
Vitamin C2 
Plasma 2.19 ± 0.11a 0.75 ± 0.09b 1.64 ± 0.13c 1.89 ± 0.14ac 
Liver 0.89 ± 0.08a 0.44 ± 0.03b 0.72 ± 0.06c 0.83 ± 0.08a 
Kidney 0.79 ± 0.06a 0.53 ± 0.05b 0.69 ± 0.05c 0.76 ± 0.06ac 
Heart 0.49 ± 0.03a 0.23± 0.02b 0.39 ± 0.03c 0.47 ± 0.04ac 
Pancreas 2.41 ± 0.18a 1.32 ± 0.10b 2.09 ± 0.16c 2.30 ± 0.18ac 
Vitamin E2 
Plasma 1.89 ± 0.14a 3.21 ± 0.27b 2.32 ± 0.19c 2.17 ± 0.18c 
Liver 5.79 ± 0.46a 3.88 ± 0.29b 4.48 ± 0.33c 4.99 ± 0.39c 
Kidney 3.59 ± 0.27a 1.30 ± 0.10b 2.89 ± 0.23c 3.02 ± 0.29a 
Heart 3.44 ± 0.25a 1.63± 0.13b 2.84 ± 0.21c 3.05 ± 0.23a 
Pancreas 2.69 ± 0.21a 1.37 ± 0.11b 2.51 ± 0.19c 2.77 ± 0.25ac 
1GSH for tissues were expressed as µg/mg protein 
2Vitamin E and vitamin C in plasma and tissues were expressed as µmole/mg tissue respectively. 
All the data are expressed as the mean ± S.D. for 6 rats. The results with different superscripts (a, b, c..) in each experimental 
group are significantly different at p < 0.05. 
(D: Diabetic; I.p: I. pes-caprae leaf ethanolic extract; GC: Glibenclamide) 
 
3.6. Histopathology of Pancreas 
Figure 2 illustrates the histology of experimental and control 
rats. The pancreas, the target tissue of diabetic etiology, 
showed severe damage in the case of STZ treated animals. 
The sinusoids as well as the islet cells of the control animals 
displayed normal tissue architecture, whereas, the STZ 
treated animals showed necrotic cells in the tissue sections. 
I. pes-caprae extract administered groups showed 
regeneration of islet cells and the same effect were observed 
with standard glibenclamide treated group.  
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3.7. Histopathology of Liver 
The histopathology of liver tissues of control animals 
revealed ideal hepatocytes whereas, STZ treated animals 
displayed distorted tissue architecture and damaged liver 
hepatocytes accompanied with degeneration in the major 
blood sinusoids were undergoing degeneration, which are 
the characteristics of STZ induced diabetic animal liver. The 
I. pes-caprae extract and glibenclamide drug-treated groups 
showed tissue regeneration with prominent near normal 
hepatocytes (Figure 3). 
 
 
3.8. Histopathology of Kidney 
The kidney, the ultrafiltration unit of the body, plays a major 
role in glucose absorption. STZ administration causes severe 
necrosis accompanied by glomeruli damage in the kidney of 
diabetic control rat. Ipomoea pes-caprae extract treated 
diabetic animals displayed considerable tissue recovery and 
the results were comparable to glibenclamide (standard 
drug) treated animals (Figure 4).  
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DISCUSSION  
Medicinal plants have created the foundation of the health 
care system throughout the world since the initial stage of 
humanity and still plant products is the major source of 
drug/formulation in the treatment of various diseases [4]. 
Previously, we have confirmed that Ipomoea pes-caprae leaf 
ethanolic extract can reduce hyperglycemia and relapse 
abnormal level of hepatic markers into normal range in STZ 
induced diabetic rats [10]. Therefore, the goal of this study is 
to observe whether Ipomoea pes-caprae leaf ethanolic 
extract ameliorated the abnormal levels of carbohydrate 
metabolizing enzymes, oxidative status and histology of 
major organs in STZ induced diabetic rats. 
Glycogen is the primary intracellular storage form of glucose 
and its quantity in various tissues is a direct manifestation of 
insulin activity as insulin supports intracellular glycogen 
deposition Pederson et al.  [23]. The reduced glycogen store 
in diabetic rats has been attributed to the loss of glycogen 
synthase-activating system and/or the increased activity of 
glycogen phosphorylase [24]. In the present study, there was 
a decrease in the hepatic glycogen content of diabetic rats 
that suggests the increased glucose output due to insulin 
deficiency. Moreover, diabetic animals showed increased 
glycogen phosphorylase activity when compared with 
control animals. Treatment with Ipomoea pes-caprae 
ethanolic leaf extract restored the levels of glycogen, 
probably by means of decreasing the activity of glycogen 
phosphorylase. 
Glucose homeostasis deals with the balance in the 
endogenous production as well as the glucose utilization by 
the target tissues [25]. Insulin, a major player in glucose 
homeostasis, is responsible for regulating the activities of 
various enzymes like hexokinase, glucose-6-phosphate 
dehydrogenase, glucose-6-phosphatase as well as fructose 
1,6-bisphosphatase, which are associated with carbohydrate 
metabolism in the body [26]. Glucokinase, a key enzyme 
involved in glycolysis, catalyzes the conversion of glucose to 
glucose 6‐phosphate (in the liver) and plays a very 
important role in maintaining blood glucose homeostasis 
[27]. Being an insulin‐dependent enzyme, the hepatic 
glucokinase activity of diabetic rats is almost entirely 
inhibited or inactivated due to the lack of insulin that 
ultimately leads to hyperglycaemia [27]. The diabetic control 
rats showed a significant reduction in the level of hexokinase 
when compared to control rats. Oral administration of I. pes-
caprae ethanol leaf extract to STZ‐induced diabetic rats 
resulted in a significant reversal in the activity of 
glucokinase, thereby increasing the oxidation of glucose. 
Several previous studies reported that glucokinase is the 
potential target for new treatment strategies for the 
management of type 2 diabetes [24, 26]. 
Glucose-6-phosphate dehydrogenase is the first and also the 
rate-limiting enzyme of the pentose phosphate pathway, 
which is involved in the formation of ribose-5-phosphate 
and also NADPH [29]. Thus, its low activity leads to a 
decrease in NADPH and makes cells very sensitive to 
oxidative damage. In the diabetic condition, the decrease in 
the activity of glucose-6-phosphate dehydrogenase hinders 
the pentose phosphate pathway [32]. In the present study, 
treatment with I. pes-caprae ethanolic leaf extract improved 
the activity of glucose-6-phosphate dehydrogenase in STZ-
induced diabetic rats that may be due to the improved level 
of insulin secretion. 
Glucose-6-phosphatase and fructose-1, 6-bisphosphatase are 
the regulatory enzymes in the gluconeogenic pathway. The 
actions of these two enzymes may be attributed to the 
increased glucose production during the diabetic condition 
by the liver [30]. The activities of hepatic glucose-6-
phosphatase and fructose-1,6-bisphosphatase increase 
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significantly in diabetic rats [31]. The oral treatment of I. 
pes-caprae ethanolic leaf extract significantly declined the 
activities of glucose-6-phosphatase and fructose-1, 6-
bisphosphatase in STZ-induced diabetic rats, which may lead 
to the suppression of glucose production from non-
carbohydrate substances. 
In the present study, the concentration of tissue TBARS was 
significantly increased in the liver and kidney and pancreas 
of diabetic rats as reported earlier in clinical and 
experimental diabetes [32]. The increased concentration of 
lipid peroxidative markers suggests an increased level of 
oxygen free radicals, either by increased production or 
decreased destruction [33]. The administration of Ipomoea 
pes-caprae leaf extract reduced TBARS in the tissues of 
diabetic rats suggesting that the extract possesses potent 
antioxidant properties. The strong antioxidant property 
displayed by the extract is in accordance with earlier 
findings [34]. 
The level of lipid peroxidation in cells is controlled by 
various cellular defense mechanisms consisting of enzymatic 
scavenger systems [35]. SOD, CAT and GPx constitute a 
mutually supportive defense system against ROS. Functions 
of these antioxidant enzymes are interconnected and a 
decrease of their activities results in the accumulation of 
lipid peroxides and increase oxidative stress in diabetic rats 
[36]. The level of enzymatic antioxidants (SOD, CAT and 
GPx) was significantly restored to near normal after 
treatment with Ipomoea pes-caprae leaf extract in diabetic 
rats. This indicates the modulatory activity of Ipomoea pes-
caprae leaf extract over SOD, CAT and GPx enzyme 
production, which help restore the oxidant status in diabetic 
rats. 
Glutathione is a tripeptide, intracellular non-enzymic 
antioxidant that protects the cellular system from adverse 
effects of lipid peroxidation. It directly scavenges free 
radicals and acts as a co-substrate for peroxide 
detoxification by glutathione peroxidases [37]. Increased 
oxidative stress due to a significant increase in aldehydic 
products of lipid peroxidation could probably decrease GSH 
availability in the cell [38]. It has been previously reported 
that the treatment with Ipomoea pes-caprae leaf extract 
result in the elevation of the GSH levels, which protects the 
cell membrane from the oxidative damage by regulating the 
redox status [39]. Vitamin C plays a vital role in the 
antioxidant system that protects all lipids from undergoing 
oxidation. Moreover, it helps in diminishing count of 
apoptotic cells [40] and helps to regenerate vitamin E from 
its oxidized state [41]. Vitamin E is a non-enzymatic 
antioxidant that helps reduce chain reactions associated 
with lipid peroxidation [42]. Vitamin E is also reported to be 
very effective in the glycemic control and also helps in 
lowering the level of HbA1c, the glycated haemoglobin, used 
as a marker to measure average blood glucose [43]. In our 
studies, diabetic control rats showed significant decline in 
the levels of GSH, vitamin C and vitamin E, while Ipomoea 
pes-caprae leaf extract administration in STZ-induced 
experimental DM rats expressed near normal levels of GSH, 
vitamin C and E. Thus, the obtained results display the 
potential of Ipomoea pes-caprae ethanolic leaf extract to 
restore the non-enzymatic and enzymatic antioxidant 
reserves. 
The most abundant cell type found in the endocrine region 
of the pancreas is the β-cell. The number of β-cell present in 
the pancreas is the most vital factor determinant of the islet 
area [32]. The pancreas of the diabetic rats displayed 
ruptured islets as well as a decrease in the number of β-cell 
count. Thus, the islet area was reduced considerably in the 
diabetic rats, which was found restored in Ipomoea pes-
caprae extract and glibenclamide treated diabetic rats. The 
restoration of damages in the pancreas may be due to the 
improved control over the activity of free radical by the 
Ipomoea pes-caprae extract. 
The liver is the vital organ that is involved in the blood 
glucose homeostasis in the body. Both the liver and kidney 
exhibit various morphological as well as functional 
modifications during diabetes [31]. The diabetic control liver 
showed damaged hepatocytes with periportal necrosis near 
the portal region with dilated as well as congestion in the 
portal vessels and inflammatory cell infiltration. Moreover, 
the diabetic kidney displayed damaged tubules, lessons and 
fatty infiltration along with thickened glomeruli matrix and 
basement membranes of proximal as well as distal 
convoluted tubules. The above observations in diabetic 
control liver and kidney tissues were in line with the 
previous reportings by Ojiako et al. [44]. Hyperglycemias as 
well as glycation of proteins are the main cause of the 
damages that occurr in diabetic rats [44]. The restoration of 
damages in the liver and kidney of diabetic rats treated with 
Ipomoea pes-caprae extract and glibenclamide may be due to 
improved glycemic control and thereby control over free 
radical production and glycation of proteins.  
The effectiveness of the Ipomoea pes-caprae leaf extract in 
ameliorating the glucose and oxidant status in the diabetic 
rats may be contributed to the presence of secondary 
metabolites such  phenols, sterols, alkaloids, flavonoids, etc., 
in leaf of Ipomoea pes-caprae [45, 46].  
CONCLUSION 
The treatment of Ipomoea pes-caprae (300 mg/kg b.w) 
notably inhibits the oxidative stress, while carbohydrate 
metabolizing enzyme levels were also improved in the liver 
of diabetic rats. These findings clearly displayed recovered 
carbohydrate metabolizing enzymes that prevent hepatic 
glucose production and also enhanced utilization of glucose 
by cells. Further study is required to find out the major 
secondary metabolites that are responsible for regulation of 
hyperglycemia in diabetic condition.  
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